Product Images Atrovent Hfa

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 12 images provide visual information about the product associated with Atrovent Hfa NDC 0597-0087 by Boehringer Ingelheim Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - atrovent 01

Chemical Structure - atrovent 01

Figure 1 - atrovent 02

Figure 1 - atrovent 02

Figure 1 - atrovent 03

Figure 1 - atrovent 03

Figure 2 - atrovent 04

Figure 2 - atrovent 04

Figure 3 - atrovent 05

Figure 3 - atrovent 05

Figure 4 - atrovent 06

Figure 4 - atrovent 06

Figure 5 - atrovent 07

Figure 5 - atrovent 07

Figure 6 - atrovent 08

Figure 6 - atrovent 08

Figure 7a - atrovent 09

Figure 7a - atrovent 09

Figure 7b - atrovent 10

Figure 7b - atrovent 10

Image - atrovent 10a

Image - atrovent 10a

PRINCIPAL DISPLAY PANEL - 17 mcg Carton - atrovent 11

PRINCIPAL DISPLAY PANEL - 17 mcg Carton - atrovent 11

Atrovent HFA is an inhalation aerosol medication that delivers 17 mcg of ipratropium bromide per actuation from the mouthpiece. The medication is distributed by Boehringer Ingelheim Pharmaceuticals Inc. and licensed under Boehringer Ingelheim International GmbH. The canister is 12.9 grams and contains 200 metered actuations. The medication must be stored between 20°C to 25°C and should not be exposed to heat over 120°F or below 10°C. It is important to read the instructions for use and avoid spraying in eyes. The product is for oral inhalation with the Atrovent HFA Inhalation Aerosol mouthpiece only.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.